Article
[Lung cancer].
Gan to kagaku ryoho. Cancer & chemotherapy - 1 Jan 2009
Ayabe Eriko, Kaira Kyoichi, Yamamoto Nobuyuki
Abstract excerpt
Biomarkers for lung cancer may be used for early detection, diagnosis, treatment selection and prognostication. They are also expected to contribute to the realization of tailored therapy. To identify the optimal therapy candidates, EGFR (epidermal growth factor receptor)mutations are biomarkers available as predictive factors for EGFR tyrosine kinase inhibitors and UGT(uridine diphosphate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
